,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'destinybreast04']
finally it s time for the #destinybreast04 trial at #asco22 plenary session: so excited to be in the 2nd row of this big room to see such unprecedented results in the #breastcancer field...this will remain one of the most important moment in the history of this disease 
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Prior @myESMO fellow. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.